The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

Only adults 65 and older or people with another health problem that puts them at higher risk will be able to get the shots ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.